로딩 중…
지수 로딩 중…
Trevi Therapeutics, Inc.
TRVI· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$17.21+5.13%
2026-06-18
Price Chart
Trevi Therapeutics, Inc.+183.53%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.44B |
| Revenue | $0.00 |
| Net Income | $-46M |
| Total Assets | $180M |
| Net Assets | $172M |
| Value | |
| P/B | 14.20x |
| FCF Yield | -1.31% |
| Profitability | |
| ROE | -26.50% |
| ROA | -25.39% |
| Financial Health | |
| Debt Ratio | 4.34% |
| Total Debt | $682000.00 |
| FCF | $-32M |
| Cash | $19M |
| Current Ratio | 24.75x |
| Performance | |
| 1Y Return | 183.53% |
| 1M Return | 29.98% |
| From 52W High | -1.18% |
| 1Y MDD | -29.50% |
| Trading | |
| Volume | 2,895,939 shares |
| Trading Value | $49M |
| Per Share | |
| EPS | $-0.29 |
| BPS | $1.26 |